Sakai S, Ryoyama K, Koshimura S, Migita S
Jpn J Exp Med. 1976 Apr;46(2):123-33.
The inhibition of transplanted tumors in animals, which were previously injected with a streptococcal preparation, OK-432, has been suggestible to be induced by direct or host mediated effects. In this paper, it was examined of immunopotentiating ability of Group A streptococcus (Su-strain), which is a active component of OK-432, with respects to reticuloendotherial system and serum complement components. Human fresh serum incubated with the heated streptococcus (HSu-coccus) was analyzed by means of immunoelectrophoresis. Activated component of C3 proactivator was observed in gamma region as immunoprecipitin line developed by rabbit anti human C3 proactivator serum, and conversion of C3 component (beta1C) to beta1A was observed in alpha region by rabbit anti human beta1C/beta1A serum. The activation of serum complement components might be occurred via alternate pathway, because EDTA inhibited the activation but EGTA did not. Meanwhile, the peritoneal exudate cells from mice injected intraperitoneally with HSu-coccus were examined with respects to cell population and their antitumor effect. On the 7th day after injection of HSu-coccus, about 90% of the peritoneal cells was lymphocytes, and 70% of these lymphocytes was susceptible to rabbit anti mouse thymus cell serum or to AKR anti thetaC3H serum. When L1210 leukemia cells preincubated with these peritoneal cells were inoculated intraperitoneally into BALB/c mice, the leukemic cells could not allowed the growth, resulting in prolongation of life-span of the experimental animals. These results suggested that nonspecific effector activity of T-derived lymphocyte induced by HSu-coccus could be one of the factors participating in antitumor activity of OK-432. Additionally, the results obtained with OK-432 were most the same as those with HSu-coccus in these respects. Further, the relation between the stimulation of leucocytes and activation of complement components was discussed.
先前注射过链球菌制剂OK-432的动物体内移植瘤受到抑制,这可能是由直接作用或宿主介导的效应所诱导的。在本文中,针对OK-432的活性成分A组链球菌(Su株)对网状内皮系统和血清补体成分的免疫增强能力进行了研究。用免疫电泳法分析了与加热后的链球菌(HSu球菌)孵育的人新鲜血清。用兔抗人C3前活化剂血清观察到γ区出现了作为免疫沉淀线的C3前活化剂的活化成分,用兔抗人β1C/β1A血清在α区观察到C3成分(β1C)向β1A的转化。血清补体成分的激活可能是通过替代途径发生的,因为EDTA抑制了激活,而EGTA则没有。同时,对腹腔注射HSu球菌的小鼠腹腔渗出细胞进行了细胞群体及其抗肿瘤作用的研究。注射HSu球菌后第7天,约90%的腹腔细胞为淋巴细胞,其中70%的淋巴细胞对兔抗小鼠胸腺细胞血清或AKR抗θC3H血清敏感。当将预先与这些腹腔细胞孵育的L1210白血病细胞腹腔接种到BALB/c小鼠体内时,白血病细胞无法生长,从而延长了实验动物的寿命。这些结果表明,HSu球菌诱导的T衍生淋巴细胞的非特异性效应活性可能是参与OK-432抗肿瘤活性的因素之一。此外,在这些方面,OK-432获得的结果与HSu球菌的结果基本相同。此外,还讨论了白细胞刺激与补体成分激活之间的关系。